Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of targeted protein degradation therapies such as PROTACs (proteolysis targeting chimeras). Its structure allows for effective linker functionality, connecting E3 ligase ligands to target protein binders, enabling the degradation of disease-causing proteins. Commonly employed in medicinal chemistry research for constructing bifunctional molecules with improved binding and pharmacokinetic properties.